News | March 14, 2023
Alpla and Inden pharma form joint venture
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Marksans' OTC Famotidine Tablets USP are acid reducers
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Time to combine innovation, access and technology to deliver positive patient outcomes
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Subscribe To Our Newsletter & Stay Updated
